1.Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis
Zhou, JD, Lee, S, La
More...
Zhou, JD, Lee, S, Lakhani, I, Yang, L, Liu, T, Zhang, YH, Xia, YL, Wong, WT, Bao, KKH, Wong, ICK, Tse, G, Zhang, QP
Less
CARDIO-ONCOLOGY[2057-3804],
Published 2022,
Volume 8,
Issue 1,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 16
2023影響因子:
3.2
发表年影響因子:
3.3